Trial intelligence / Profile preview

Ethacrynic acid via Retroject for advanced glaucoma

NCT02051946Phase 2Completed

Start
May 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ethacrynic acid in Glaucoma. Started May 2014; status: completed.

02

Drugs

ethacrynic acid
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT02051946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02051946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call